PATENT CLAIM ANALYSIS

Application Number: 15885652
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["606", "013000"]

Abstract:
Devices and methods that regulate the innervation of the kidney by detection and modification of the aorticorenal ganglion. Devices for percutaneous detection and treatment of the aorticorenal ganglion via a blood vessel to modify renal sympathetic activity.

Claim (Index 1):
A method for treating hypertension comprising:\n advancing a treatment catheter system comprising a plurality of spaced apart tissue stimulation elements and a corresponding plurality of spaced apart tissue modification elements within a patient to a location at or near which an aorticorenal ganglion is thought to exist; electrically stimulating said patient with a first of said plurality of spaced apart tissue stimulation elements of said treatment catheter system at said location, without resulting in a permanent change to tissue of the aorticorenal ganglion and/or a permanent change to kidney nerve activity; detecting a first physiological response of the patient that indicates said first of said plurality of spaced apart tissue stimulation elements of said treatment catheter system is not in proximity to said aorticorenal ganglion, responsive to said stimulating when electrically stimulating said patient with said first of said plurality of spaced apart tissue stimulation elements of said treatment catheter system at said location; electrically stimulating said patient with a second of said plurality of spaced apart tissue stimulation elements of said treatment catheter system at said location, without resulting in a permanent change to tissue of the aorticorenal ganglion or a permanent change to kidney nerve activity; detecting a second physiological response of the patient that indicates said second of said plurality of spaced apart tissue stimulation elements of said treatment catheter system is in proximity to said aorticorenal ganglion when electrically stimulating said patient with said second of said plurality of spaced apart tissue stimulation elements of said treatment catheter system at said location; and ablating said aorticorenal ganglion with a corresponding second of said plurality of spaced apart tissue modification elements of said treatment catheter system when detecting said first physiological response of the patient that indicates said first of said plurality of spaced apart tissue stimulation elements of said treatment catheter system is not in proximity to said aorticorenal ganglion and detecting said second physiological response of the patient that indicates said second of said plurality of spaced apart tissue stimulation elements of said treatment catheter system is in proximity to said aorticorenal ganglion, said ablating resulting in a permanent change to the tissue of the aorticorenal ganglion and/or a permanent change to kidney nerve activity.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 86.0
- Lexical Diversity: 1.44444
- Patent Class: 606.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14269001', '15195998', '14691553', '14241061', '14247244']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7582016440917863
- 35 USC 102 Novelty (BERT): 0.6097314095142595
- Combined Prediction Score: 0.7433546206340336
- Mean Citation Score: 340.862094
- Max Citation Score: 563.12146
- Similarity Product: 556.003202313447

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test